Pharmaron (Chengdu) Clinical Services
Pharmaron (Chengdu) Clinical Services is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Furmonertinib Compared to Platinum-Based Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (FURVENT)
Sponsor Arrivent Biopharma Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase II, Open Label, Multicenter, Single Arm Study of WSD0922-FU for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer whose Disease has Progressed with First-Line Osimertinib Treatment and whose Tumors harbor a C797S mutation within the Epidermal Growth Factor Receptor Gene
Sponsor Wayshine Biopharm Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase I-II, First-in-Human Study of SKB264 in Patients with Locally Advanced Unresectable /Metastatic Solid Tumors Who are Refractory to Available Standard Therapies
Sponsor Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
- Start (EU)
- Not reported
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Pharmaron (Chengdu) Clinical Services?
The 2026-10-09 snapshot links Pharmaron (Chengdu) Clinical Services to 3 distinct CTIS trials. Recorded services include Safety reporting & pharmacovigilance, PK testing. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Pharmaron (Chengdu) Clinical Services?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Pharmaron (Chengdu) Clinical Services conducted?
The linked trials record locations in 5 countries, including France, Spain, Italy, Hungary, Netherlands. These are trial locations, not confirmed office locations or countries where Pharmaron (Chengdu) Clinical Services delivered services.
What can this page tell me about Pharmaron (Chengdu) Clinical Services's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Pharmaron (Chengdu) Clinical Services. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Pharmaron (Chengdu) Clinical Services Co. Ltd.